Medicus Pharma Ltd. (MDCX)
1.95
+0.23
(+13.37%)
USD |
NASDAQ |
Nov 13, 16:00
1.93
-0.02
(-1.03%)
After-Hours: 19:59
Medicus Pharma Shareholders Equity (Quarterly) : -7.421M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -7.421M |
| June 30, 2026 | -1.243M |
| March 31, 2026 | 0.9502M |
| December 31, 2025 | -0.0493M |
| September 30, 2025 | -0.6541M |
| June 30, 2025 | 2.381M |
| March 31, 2025 | 1.492M |
| December 31, 2024 | 2.180M |
| Date | Value |
|---|---|
| September 30, 2024 | 2.585M |
| June 30, 2024 | 4.715M |
| March 31, 2024 | -0.4509M |
| December 31, 2023 | 0.8429M |
| September 30, 2023 | 2.594M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -9.003M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 657.52M |
| enGene Therapeutics, Inc. | 230.29M |
| Xenon Pharmaceuticals, Inc. | 1.146B |
| Psyence Biomedical Ltd. | 11.87M |
| AVITA Medical, Inc. | -31.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.24M |
| Total Liabilities (Quarterly) | 17.63M |
| Debt to Equity Ratio | -2.003 |
| Current Ratio | 0.654 |
| Net Debt Paydown Yield | -15.07% |